CSIMarket
 
HOSPIRA, INC.  (HSP)
Other Ticker:  
 
 

Hospira Growth Comparisons

Select each growth Category to receive further Information



HSP Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) 14.12% 3.73% 10.21% 3.91%
Q / Q Revenue Growth (Q3 MRQ) 1.3% -4.07% -0.62% 0.22%
Y / Y Revenue Growth (for 12 months ending Q3 TTM) 10.06% -4.98% 0.3% %
Seq. Revenue Growth (for 12 months ending Q3 TTM) 3.33% 0.6% 2.82% 0.91%
Revenue 5 Year Average Growth 1.98% 7.76% 15.09% 10.83%
Expected Revenue Growth (Y/Y) 2.5% 2.5% 1.89% 0.98%


HSP's Growth Comparisons in III. Quarter 2014




Hospira improved it's Revenue by 14.12% year on year in the third quarter 2014, and outpaced the 3.73% growth in Major Pharmaceutical Preparations industry, and 10.21% improvement in the Healthcare sector. Although Major Pharmaceutical Preparations industry's Sales gains were softer then 3.91% overall market growth, Hospira, Inc. and the Healthcare sector have delivered above average market Sales growth.

Comparing company's Revenue to the second quarter results, sales were higher by 1.3% . On the yearly basis, average annual sales growth for Hospira is 1.98%, while S & P 500's including only Businesses with the third quarter 2014 earnings, average annual sales growth is 10.83% over the past five years.


Growth Rates of HSP's Income in the third quarter 2014


HSP Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) 663.42% 13.82% 9.28% 1.92%
Seq. Operating Income Change (Q3 MRQ) 128.64% -5.5% -9.46% -3.12%
Y / Y Operating Income Growth (Q3 TTM) - -5.6% 1.34% 8.76%
Seq. Operating Income Growth (Q3 TTM) 70.08% 3.11% 2.2% 0.45%
Operating Income 5 Year Avg. Change -49.74% 7.75% 5.1% 22.87%


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) 8247.37% 25.61% 19.05% 5.16%
Seq. Income from Cont. Ops. Change (Q3 MRQ) 123.7% -11.69% -17.82% -0.69%
Y / Y Income from Cont. Ops. Change (Q3 TTM) - 6.7% 13.95% 2.11%
Seq. Income from Cont. Ops. Change (Q3 TTM) 89.95% 6.08% 4.17% 1.23%
Income from Cont. Ops. 5 Year Avg. Change - -2.88% 1.99% 41.52%

HSP Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) 8247.37% 23.51% 18.6% 7.25%
Q / Q Net Income Growth (Q3 MRQ) 123.7% -10.94% -17.27% -1.1%
Y / Y Net Income Change (Q3 TTM) - -24.41% -6.41% 8.81%
Seq. Net Income Change (Q3 TTM) 89.95% 5.8% 4.14% 1.71%
Net Income 5 Year Avg. Growth - 6.79% 6.96% 41.64%

HSP's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) 9300% 208% 19.05% 5.16%
Seq. EPS from Cont. Ops. Change (Q3 MRQ) 123.81% -6.16% -17.82% -0.69%
Y / Y EPS from Cont. Ops. Change (Q3 TTM) - - - -
Seq. EPS from Cont. Ops. Change (Q3 TTM) 89.26% - 15.17% -
EPS from Cont. Ops. 5 Year Avg. Growth - -45.14% 1.99% 41.52%



HSP EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) 9100% 202.85% 18.6% 41.52%
Q / Q EPS Net Growth (Q3 MRQ) 119.05% -5.37% -17.27% -1.1%
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - - -92.48% 19.56%
Seq. EPS Net Change (for 12 months ending Q3 TTM) 88.35% - 19.61% 0.5%
EPS Net 5 Year Avg. Change - 6.79% 6.96% 41.64%
Expected EPS Growth (Y/Y) - - 123.59% 14.14%



Reporting 9100% surge year on year in the third quarterEPS, Hospira led the 202.85% surge in Major Pharmaceutical Preparations industry, and 18.6% improvement in the Healthcare sector. Above average income per share gains in Healthcare and Major Pharmaceutical Preparations industry, helped to elevate overall market growth to 7.25%.

Company's sequential EPS growth rate was impressive 119.05% from the second quarter. Average yearly income per share growth for Hospira is 1.98%, while S & P 500's average annual income per share growth is 41.64% over the five years, including only Businesses with the third quarter 2014 earnings results.

HSP Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) - 11.04% 16.67% -17.26%
Seq. Free Cash Flow Change (Q3 MRQ) -4.3% 41.29% 28.94% 26.32%
Y / Y Free Cash Flow Change (Q3 TTM) - 16.82% 11.69% -16.38%
Seq. Free Cash Flow Change (Q3 TTM) 92.46% -0.91% 3.16% -5.36%
Free Cash Flow 5 Year Avg. Change -5.36% 3.03% 4.46% 8.38%

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) - - - -95.91%
Seq. Net Cash Flow Change (Q3 MRQ) - - - -
Y / Y Net Cash Flow Change (Q3 TTM) - - - -
Seq. Net Cash Flow Change (Q3 TTM) - - - -
Net Cash Flow 5 Year Avg. Change -36.03% - -11.11% -

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) -1.67% 3.6% 11.66% 9.12%
Seq. Capital Expenditures Change (Q3 MRQ) 5.02% 1.64% 7.31% 3.97%
Y / Y Capital Expenditures Change (Q3 TTM) -91.36% 6.89% 2.01% 3.91%
Seq. Capital Expenditures Change (Q3 TTM) -5.21% 2.32% 3.26% 1.85%
Capital Expenditures 5 Year Avg. Change - -0.01% 0.84% 2.9%

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 





Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

USB's Profile

Stock Price

USB's Financials

Business Description

Fundamentals

Charts & Quotes

USB's News

Suppliers

USB's Competitors

Customers & Markets

Economic Indicators

USB's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071